As part of the agreement, ASM Technologies will buy 10 acres of land from the Karnataka Industrial Areas Development Board ...
While the 1970s spelled the end of the OG muscle car era, there were still some high-powered performance machines on the road ...
Nisun International Enterprise Development Group Co., Ltd ("Nisun International" or the "Company") (Nasdaq: NISN), a technology and industry driven integrated supply chain solutions provider, today ...
The FDA has granted a 510 (k) clearance to the Ibex Prostate Detect software (formerly Galen Second Read). The Ibex Prostate ...
ASM Technologies Limited invests Rs. 510 crores in expanding ESDM capacity, acquiring land in Karnataka for design facility.
ASM Technologies plans to invest Rs 510 crore in Karnataka to expand its Design-Led Manufacturing and precision engineering capacity, creating new jobs and boosting the state's electronics sector.
17d
GlobalData on MSNFDA grants 510(k) clearance for Imperative Care’s stroke thrombectomy systemThe US Food and Drug Administration (FDA) has granted 510 (k) clearance for Imperative Care’s Zoom System, marking an advancement in stroke thrombectomy procedures. The clearance marks it as the first ...
Despite lower year-over-year comparisons, Cirrus Logic demonstrated strong quarterly performance, with its gross margin ...
16d
KitGuruTech on MSNLEO analyses the NZXT 510 ELITE CaseYes this is a repost - our final export corrupted in a few places so yeah, here we go again! Leo spent some time recently with the NZXT 510 Elite Case - and he covers all the major points today - both ...
Clean Core Thorium Energy (CCTE) has raised a $15.5M Series Seed round of financing to advance the ANEEL fuel - a patented blend ...
Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 billion) as it ...
The FDA granted 510(k) clearance to a large-bore stroke thrombectomy ... The Zoom system was also associated with a core-lab adjudicated rate of symptomatic intracranial hemorrhage of 0.9% and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results